To develop and implement quality improvement programs for the treatment of acute coronary syndrome (ACS) in China based on the successful experience of the AHA-Get with the Guidelines program. This program will use data collection, analysis, feedback, and process improvement to extend the use of evidence-based guidelines throughout the healthcare system and improve patient care of acute coronary syndrome.
Study Type
OBSERVATIONAL
Enrollment
124,363
Beijing An Zhen Hospital
Beijing, China
The overall composite of 11 performance measures for ACS care
Performance measures for ACS care including: 1. Proportion of patients received aspirin at arrival 2. Proportion of patients received fibrinolytic therapy within 30 mins (STEMI) 3. Proportion of patients received primary percutaneous coronary intervention within 90 mins (STEMI) 4. Proportion of patients received reperfusion therapy (STEMI) 5. Proportion of patients with aspirin prescribed at discharge 6. Proportion of patients with clopidogrel or other P2Y12 inhibitors prescribed at discharge 7. Proportion of patients with beta-blocker prescribed at discharge 8. Proportion of patients with statin prescribed at discharge 9. Proportion of patients received evaluation of left ventricular systolic function 10. Proportion of left ventricular systolic dysfunction patients with ACEI or ARB prescribed at discharge 11. Proportion of patients received smoking cessation advice/ counseling
Time frame: Duration of hospital stay, an expected average of 1 week
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.